Type A - Cboe Global Markets, Inc. (CBOE) 20261102 Stock Analysis

📅 Cboe Global Markets Key Upcoming Events

• November 30, 2026 Quarterly Ex-Dividend Date (Confirmed)
  • Description: Shares are scheduled to trade ex-dividend for the quarterly distribution. Dividend continuity supports shareholder returns, although the modest yield makes earnings growth more important to the investment thesis.
• February 05, 2027 Q4 and FY2026 Earnings Release (Estimated)
  • Description: This date follows the company’s typical early-February annual-results reporting pattern and is not an officially announced schedule. Investors will assess whether stronger index-options activity, Data Vantage growth, and expense discipline carried into year-end; the estimate may change.

🏢 Step 1: Cboe Global Markets Company Overview & Business Model

Q1-A1. What is Cboe Global Markets?

• Company Name (Ticker): Cboe Global Markets, Inc. (CBOE)
• Sector: Financials
• Exchange: Cboe BZX (BATS)
• Founded: 1973 (Cboe exchange predecessor)
• Listing Date: June 15, 2010
• Fiscal Year End: December
• Headquarters: United States, Chicago
• CEO: Craig Donohue
• Market Cap: $36.14B (approximately, based on the latest intraday quotation)
• Shares Outstanding: 104.33M
• Current Stock Price: $346.36
• Annual Dividend Yield: 0.99%
• Ex-dividend Date: November 30, 2026 (ET)
• As-of: November 02, 2026 (ET)

Q1-A2. How Does Cboe Global Markets Make Money?

• Exchange Transaction and Clearing Fees: Cboe operates financial exchanges and clearing infrastructure, earning fees when investors trade options, equities, futures, and foreign exchange products. Particularly valuable franchises include S&P 500 Index options (SPX), Cboe Volatility Index options and futures (VIX), and related proprietary derivatives.
• Proprietary Index-Options Economics: Exclusive product licenses, market liquidity, and institutional adoption allow Cboe to capture economically attractive trading revenue. Customers include market makers, brokers, institutional asset managers, hedge funds, and retail investors accessing the markets through intermediaries.
• Market Data and Connectivity Revenue: Cboe Data Vantage sells market information, analytics, connectivity, and access services. These revenues diversify the company beyond transaction volumes and create recurring relationships with financial institutions.
• Clearing and Technology Infrastructure: Clearing services, matching engines, market access, and specialized trading technology support the exchange ecosystem. Trading activity increases the value of its liquidity network, while operating systems and regulatory approvals create meaningful barriers to new competitors.

Q1-A3. Cboe Global Markets’ Revenue Segments & Core Income Sources

• Q3 2026 Net Revenue: $712.20M, compared with $605.50M in Q3 2025, representing approximately 17.6% growth. Net revenue excludes transaction-related cost of revenues and is more economically informative than gross revenue for an exchange operator.
  • Derivatives Markets: $401.70M, approximately 56.4% of consolidated net revenue, growing 22.0% YoY. Index-options volume, particularly SPX and short-dated contracts, is the largest earnings driver.
  • Data Vantage: $179.10M, approximately 25.1% of net revenue, growing 12.7% YoY. Market data, access, and connectivity provide a more recurring complement to transaction-based activities.
  • Cash and Spot Markets: $131.40M, approximately 18.5% of net revenue, growing 12.0% YoY. This includes cash-equity, foreign-exchange, and related trading infrastructure.
• Nine-Month Revenue Mix: For the nine months ended September 2026, Derivatives Markets generated $1.22B, Data Vantage $534.70M, and Cash and Spot Markets $415.20M, against total net revenue of $2.17B.
• Growth Concentration: Derivatives contributed approximately 57.8% of Q3 net-revenue growth. This concentration makes index-options activity the most consequential variable for future earnings revisions.
• Reporting Distinction: Transaction and regulatory pass-through expenses can make gross revenue materially larger than net revenue. Comparing Cboe’s gross sales directly with competitors’ net-revenue presentations would distort profitability and valuation.

Q1-A4. Who Are Cboe Global Markets’ Competitors?

• CME Group: A major competitor in derivatives infrastructure, particularly futures and interest-rate products. CME’s benchmark contracts and clearing network have similarly strong liquidity-driven competitive advantages.
• Intercontinental Exchange (ICE): Competes in derivatives, cash markets, clearing, data, and financial infrastructure. ICE has substantial recurring data and technology activities, creating both competitive overlap and diversification differences.
• Nasdaq: Competes in equity and options trading, market technology, and data services. Nasdaq’s software and financial-technology mix differs from Cboe’s comparatively concentrated index-derivatives exposure.
• Alternative Trading Venues: Broker internalization, alternative trading systems, competing options exchanges, and electronic market makers can challenge execution economics and transaction market share.
• Competitive Position: Cboe’s proprietary SPX and VIX ecosystem is particularly difficult to replicate because institutional hedging demand, exclusive licenses, liquidity, and established trading practices reinforce one another. However, its broader cash-equities and multi-listed options businesses face substantial competition.

Q1-A5. Cboe Global Markets Key Events: Past 12 Months

• February 2026 Expanded Focus on Proprietary Derivatives and Operating Efficiency
  • Description: Management’s strategy emphasized differentiated index products, market-data expansion, and disciplined investment. These priorities became increasingly important as derivatives outperformed other activities.
• July 31, 2026 Q2 2026 Earnings Release
  • Description: Net revenue increased 25% YoY to $731.60M and adjusted EPS increased 45% to $3.56. Management raised its organic net-revenue growth outlook to the mid-to-high teens, confirming stronger-than-expected operating momentum.
• July 31, 2026 Completed Sale of Cboe Australia
  • Description: The divestiture simplified the international operating portfolio and generated a gain recognized in subsequent results. The transaction affects reported GAAP earnings and requires normalization when assessing recurring profitability.
• October 2026 Extended Exclusive S&P Licensing Arrangements Through 2051
  • Description: The extension provides unusually long visibility for key SPX and VIX product franchises, reducing uncertainty about the continuity of an important part of Cboe’s economic moat.
• October 2026 Advanced Cboe Predicts and Event-Contract Expansion
  • Description: The company received regulatory approvals supporting company-KPI event contracts and anticipated a November product launch. Commercial adoption remains unproven, but the initiative provides a potential additional transaction-fee opportunity.
• October 30, 2026 Q3 2026 Earnings Release
  • Description: Net revenue rose 18% to $712.20M, GAAP diluted EPS increased 43% to $4.08, and adjusted EPS increased 36% to $3.63. Management raised its 2026 organic net-revenue growth target to the high teens and lowered adjusted operating-expense guidance to $830M-$845M.

Q1-A6. Step 1 Key Takeaways

• Step 1 Summary: Cboe operates a high-margin financial-exchange ecosystem anchored by proprietary index derivatives and reinforced by data, connectivity, and clearing services. Exceptional recent earnings growth and the extension of critical product licenses strengthen the franchise, while concentrated derivatives exposure remains its defining vulnerability.

🏰 Step 2: Cboe Global Markets’ Economic Moat, Growth & Capital Allocation

Q2-A1. Does Cboe Global Markets Have a Durable Economic Moat?

• Liquidity Network Effects: An exchange becomes more valuable as trading volume and available liquidity increase. Market makers gravitate toward active venues, tightening spreads and attracting additional trading activity.
• Exclusive Intellectual Property: The S&P licensing extension through 2051 provides long-term contractual support for Cboe’s most important proprietary index-options franchises. Competing venues cannot simply replicate the same licensed contracts.
• Switching Costs: Institutional trading systems, execution algorithms, risk models, and hedging practices are deeply integrated with exchange products. Switching is possible but introduces execution, liquidity, and operational costs.
• Pricing Power: Proprietary index products offer stronger pricing economics than commoditized equities execution. Cboe can benefit from both higher transaction volumes and favorable product mix.
• Competitive Limitations: Cboe does not control all trading activity. Multi-listed options and cash equities remain competitive, while regulatory authorities can influence market structure, fee schedules, and product availability.
• Economic Evidence: Q3 2026 adjusted operating margin reached 71.4% on net revenue, compared with 65.3% a year earlier. This is consistent with strong operating leverage and differentiated exchange economics.

Q2-A2. Is Cboe Global Markets’ Growth Sustainable?

• Industry Structure and Outlook: Exchange infrastructure benefits from long-term growth in derivatives adoption, sophisticated hedging, electronic execution, and financial-data consumption. Demand is structural but individual trading-volume categories remain cyclical.
• Growth Sustainability: SPX and VIX product development, expanding short-dated options activity, global access, and Data Vantage monetization provide multiple growth channels. Nevertheless, the exceptionally strong 2026 comparison may represent an elevated activity baseline.
• Downside Scenarios:
  • 1 Volatility Normalization: A prolonged decline in hedging demand or derivatives activity could reduce transaction growth and weaken operating leverage.
  • 2 Competitive Product Substitution: Investors could shift toward competing futures, ETFs, or alternative hedging instruments, slowing market-share and fee growth.
  • 3 Regulatory Constraints: Changes affecting options trading, exchange pricing, market access, or event contracts could restrict monetization opportunities.

Q2-A3. How Does Cboe Global Markets Allocate Capital & Return Cash?

• Capital Priorities: Management balances proprietary product development, trading and clearing technology, acquisitions, dividends, debt management, and share repurchases.
• Dividend Policy: The quarterly dividend of $0.86 per share represents $3.44 annually, approximately a 0.99% yield at the reference price. The payout is sustainable relative to current earnings but is not the primary investment attraction.
• Share Repurchases: The company expanded its repurchase authorization by $550M alongside Q3 results. Actual execution prices and repurchase volumes will determine whether the program enhances per-share value.
• Reinvestment Economics: High returns on invested capital support reinvestment in scalable proprietary derivatives and data infrastructure. Incremental technology investments can be highly productive when trading adoption increases without proportionate operating costs.
• Capital Allocation Constraint: Historical shareholder yield has remained modest relative to the operating franchise’s profitability. Continued buybacks at elevated valuations could produce weaker incremental returns than reinvestment or repurchases at discounted prices.

Q2-A4. Step 2 Key Takeaways

• Scoring Rationale:
  • Economic Moat (9/10): Exclusive index-product licensing, liquidity network effects, and exceptional margins establish a durable moat, although competition remains meaningful outside proprietary products.
  • Growth Sustainability (7/8): Strong structural derivatives and data demand supports expansion, with some reliance on elevated trading activity.
  • Capital Allocation (6/7): High reinvestment returns, a sustainable dividend, and additional repurchase authorization support shareholder value, offset by modest shareholder yield.
• 📊 Step 2 Score: 22/25 pts (Economic Moat 9/10 + Growth Sustainability 7/8 + Capital Allocation 6/7)
• Step 2 Summary: Cboe’s proprietary derivatives franchise is structurally advantaged, and its capital-light operating model supports durable compounding. The largest uncertainty is how much recent trading-volume strength will persist.

💰 Step 3: Is Cboe Global Markets Profitable? Financial Health Analysis

Q3-A1. Cboe Global Markets’ Growth & Profitability Trends

• Strong Q3 Net-Revenue Expansion: Q3 2026 net revenue increased from $605.50M to $712.20M, approximately 17.6% YoY. For the first nine months, net revenue increased from $1.76B to $2.17B, approximately 23.6%, demonstrating that the acceleration extends beyond a single quarter.
• Operating Leverage Accelerated Earnings: Q3 GAAP operating income increased from $370.30M to $534.30M, while adjusted operating income rose from $395.30M to $508.20M. Adjusted operating margin increased from 65.3% to 71.4%, as revenue growth exceeded underlying expense growth.
• Net Income and EPS: Quarterly GAAP net income attributable to common shareholders increased from $299.30M to $426.70M, with diluted EPS advancing from $2.85 to $4.08. Adjusted diluted EPS increased from $2.67 to $3.63, confirming that the earnings improvement was not solely attributable to nonrecurring gains.
• Nine-Month Earnings: GAAP net income attributable to common shareholders reached approximately $1.16B for the first nine months of 2026, versus $782.60M in the comparable 2025 period. Adjusted diluted EPS increased from $7.62 to $10.88.
• Free Cash Flow Growth: Standardized trailing operating cash flow reached approximately $2.63B, while capital expenditure was approximately $96.40M, implying reported FCF near $2.53B. Clearing-related and other operating-balance movements substantially influence this figure, so it should not be treated as entirely recurring distributable cash.
• Profitability Interpretation: Earnings growth is supported by genuine operating leverage, but the GAAP earnings increase and standardized cash-flow growth both require normalization for transactions and balance movements unrelated to sustainable exchange economics.

Q3-A2. How Profitable Is Cboe Global Markets? (Margins & ROIC)

• Operating Profitability: Q3 adjusted operating margin of 71.4%, up 6.1 percentage points YoY, demonstrates substantial incremental profitability on net revenue. The GAAP operating margin was 75.0%, influenced by nonrecurring items.
• Return on Invested Capital: Latest standardized ROIC is approximately 29.1%, versus approximately 22.7% in FY2025 and 16.9% in FY2024, supporting an improving capital-efficiency trend.
• Cost of Capital: A compiled WACC estimate near 6.4% implies an ROIC-WACC spread of approximately 22.7 percentage points. WACC estimates depend on beta, market risk premiums, debt costs, and target capital structure, so the spread should be interpreted directionally.
• Return on Equity: ROE of approximately 27.4% reflects the asset-light economics and growing profitability of the franchise.
• Peer Position: Cboe’s proprietary index-options economics support unusually strong operating margins, although direct comparisons with CME, ICE, and Nasdaq must normalize revenue presentation, business mix, and clearing activities.

Q3-A3. What Drives Cboe Global Markets’ Returns? (ROIC Breakdown)

• Selected Efficiency Indicators: Derivatives transaction activity, net-revenue yield, and operating leverage are the most meaningful indicators because Cboe monetizes electronic trading networks rather than manufacturing inventory.
  • Derivatives Activity: Index-options average daily volume increased approximately 24% YoY in Q3 2026, providing the primary operating driver behind the 22% derivatives net-revenue increase.
  • Net-Revenue Yield: Derivatives net revenue reached $401.70M, making product mix and realized revenue per contract crucial to earnings quality. A complete contract-level blended fee series was not established.
  • Operating Leverage: Adjusted operating income increased approximately 28.6% on 17.6% net-revenue growth, confirming that incremental exchange activity generated disproportionate profit growth.
• Operational Driver: Higher utilization of existing exchange infrastructure, combined with proprietary product fees, creates attractive incremental margins without equivalent growth in physical capital requirements.
• Return Driver Conclusion: Increasing transaction activity and improved product mix expand profit relative to invested capital, supporting strong ROIC and substantial economic value creation.

Q3-A4. Are Cboe Global Markets’ Earnings High Quality?

• Operating Earnings Quality: Adjusted Q3 operating income grew 29% while adjusted net income increased 36%, supporting the conclusion that a substantial portion of earnings growth came from recurring operating activity.
• Cash Conversion: Standardized TTM operating cash flow of $2.63B exceeds approximately $1.48B of TTM net income, implying OCF/NI around 1.77x. However, roughly $1.46B of cash-flow movement in other net operating assets makes the headline conversion unusually favorable.
• Normalization Requirement: Q3 included a $71.50M divestiture gain, while transaction-related provisions and other adjustments affected reported profitability. Adjusted operating earnings and earnings per share are better recurring-performance measures than unadjusted GAAP growth alone.
• Historical Comparison: FY2025 standardized operating cash flow was approximately $1.75B versus $1.10B in FY2024. Cash generation improved, but year-to-year operating-balance movements complicate a clean recurring FCF interpretation.

Q3-A5. Is Cboe Global Markets’ Balance Sheet Healthy? (Debt & Leverage)

• Leverage: Latest standardized debt/EBITDA is approximately 0.76x and net debt/EBITDA is negative, indicating a net-cash position under the provider’s financing definitions.
• Interest Coverage: EBIT/interest expense is approximately 36.4x, indicating substantial capacity to meet financing expenses from operating earnings.
• Liquidity: A current ratio near 1.61x suggests a manageable near-term financial position. Exchange clearing-related balances should be evaluated separately from unrestricted corporate liquidity.
• Financial Flexibility: Strong earnings, low conventional leverage, and access to internally generated cash provide capacity for dividends, buybacks, and organic investment.
• Refinancing Risk: Existing leverage appears manageable relative to earnings. The more important liquidity distinction is between corporate cash and amounts associated with clearing or regulatory obligations.

Q3-A6. Step 3 Key Takeaways

• Scoring Rationale:
  • Profitability·Capital Efficiency (10/10): Exceptional adjusted operating margins, strong ROIC, and improving earnings demonstrate substantial economic profitability.
  • Cash Flow·Profit Quality (6/8): Operating earnings are strong, but clearing-related balance movements and a divestiture gain complicate reported cash conversion and GAAP earnings.
  • Financial Soundness·Debt Management (7/7): Low leverage, net cash, strong interest coverage, and resilient operating profitability support financial stability.
• 📊 Step 3 Score: 23/25 pts (Profitability·Capital Efficiency 10/10 + Cash Flow·Profit Quality 6/8 + Financial Soundness·Debt Management 7/7)
• Step 3 Summary: Cboe combines strong profitability with a robust balance sheet. Its operating earnings are more economically informative than headline cash-flow growth because financial-market infrastructure creates unusual working-capital movements.

🔎 Step 4: Cboe Global Markets Forensic Accounting & Dilution Review

Q4-A1. Does Cboe Global Markets Have Accounting Red Flags?

• Revenue recognition: not found
  • Evidence: Exchange transaction fees and data services have identifiable contractual revenue sources. No substantiated material revenue-recognition irregularity was identified in the reviewed disclosures.
• Cost capitalization: not found
  • Evidence: Capital expenditure is modest relative to earnings, and the reviewed figures do not establish aggressive capitalization of ordinary operating expenses.
• Sharp increase in accounts receivable and inventory: not found
  • Evidence: Inventory is economically immaterial for an electronic exchange operator. Standardized TTM receivables movements were negative $91.70M, requiring monitoring but not independently establishing fictitious sales.
• Non-recurring adjustment (normalization): discovered
  • Evidence: The $71.50M gain associated with the Australian business divestiture and a $14.00M incremental Consolidated Audit Trail-related receivable reserve affect GAAP comparison periods. Adjusted profitability should be reconciled with the reported figures.

Q4-A2. Is Cboe Global Markets Overspending? (Capex & Capital Cycle)

• ➖ Not applicable: Cboe primarily operates electronic financial markets and associated technology infrastructure. Its capital requirements are not governed by the physical-capacity oversupply cycle typical of commodity producers or heavy manufacturers; software execution capacity, systems resilience, and market liquidity are more relevant.

Q4-A3. How Sound Is Cboe Global Markets’ Cash Flow?

• Positive Cash Generation: Standardized TTM operating cash flow of approximately $2.63B and capital expenditure of $96.40M produce reported FCF of approximately $2.53B.
• Working-Capital Distortion: Other net operating assets contributed approximately $1.46B to operating cash flow. Such movements can reflect clearing and settlement activity rather than permanently available cash.
• Underlying Funding Capacity: Positive operating earnings, low leverage, and modest capital expenditure support internal funding capacity even after recognizing that reported FCF overstates a simple recurring owner-cash measure.
• Warning Signal Assessment: There is no demonstrated persistent operating cash deficit or dependence on emergency equity financing, although cash-flow normalization remains important.

Q4-A4. Is Cboe Global Markets Diluting Shareholders?

• ⏪ Confirmed (Past) Dilution: Shares outstanding decreased approximately 0.17% YoY to 104.33M, indicating that repurchases broadly offset equity compensation and issuance. TTM stock-based compensation was approximately $55.20M.
• ⏩ Potential (Future) Dilution & Overhang: Equity awards and ongoing incentive compensation create ordinary dilution pressure, but current evidence does not indicate a large near-term equity-financing overhang. Repurchase authorization increases provide capacity to offset future awards, subject to execution.

Q4-A5. Data Integrity Check

• Period: Q3 2026 and September 2026 TTM figures are distinguished from FY2025 historical comparisons ➡ (Pass)
• Definition: Gross revenue, net revenue, GAAP earnings, adjusted earnings, and standardized FCF are explicitly differentiated ➡ (Pass)
• Number of Shares: Current outstanding shares are distinguished from diluted weighted-average EPS denominators ➡ (Pass)
• Unit: Monetary figures are presented in USD, with financial statements normalized to millions or billions as appropriate ➡ (Pass)
• Single Value Confirmation: The selected reporting periods and core definitions are consistent, with clearing-related cash movements treated separately from normalized operating performance ➡ (Pass)

Q4-A6. Step 4 Key Takeaways

• Scoring Rationale:
  • Accounting anomalies·distortion signals (6/8): No material accounting misconduct is established, but nonrecurring gains and cash-flow classification require normalization.
  • Cash flow warning signals (6/7): Strong positive earnings and cash generation mitigate concerns, although operating-balance movements materially distort headline FCF.
  • Dilution factors (5/5): Share count is slightly declining, with no identified large near-term financing overhang.
• 📊 Step 4 Score: 17/20 pts (Accounting anomalies·distortion signals 6/8 + Cash flow warning signals 6/7 + Dilution factors 5/5)
• Step 4 Summary: Cboe’s financial reporting reveals manageable normalization issues rather than substantiated accounting misconduct. Low dilution and strong operating fundamentals support financial quality.

👔 Step 5: Cboe Global Markets Management & Shareholder Alignment

Q5-A1. Can You Trust Cboe Global Markets’ Management? (Guidance Track Record)

• Guidance Execution: Management raised its organic net-revenue outlook twice during 2026 as results exceeded earlier expectations. The latest high-teens organic growth target is consistent with strong year-to-date operating performance.
• Expense Discipline: Adjusted operating expense guidance declined to $830M-$845M from $838M-$853M, supporting the credibility of management’s operating-leverage objectives.
• Strategic Execution: The extension of the S&P licensing arrangements through 2051 materially strengthens the long-term stability of proprietary index products.
• Management Transition: Craig Donohue leads the company through a period of rapid derivatives growth and strategic portfolio optimization. Recent execution is favorable, although several initiatives, including event contracts, remain commercially unproven.

Q5-A2. What Are Cboe Global Markets Insiders Doing?

• Reported Open-Market Activity: The reviewed trailing-year records indicate five insider open-market sales totaling approximately $2.33M and no identified open-market purchases. The net flow is negative.
• Notable Transactions:
  • Edward J. Fitzpatrick: Director; sold approximately 3,900 shares on February 18, 2026, for approximately $1.13M.
  • Alexander J. Matturri Jr.: Director; sold approximately 1,500 shares on February 18, 2026, for approximately $428K.
  • Allen Wilkinson: Senior Vice President and Chief Accounting Officer; sold 248 shares on February 23, 2026, for approximately $72.60K.
  • Janet P. Froetscher: Director; sold 1,223 shares on May 18 and 937 shares on August 12, 2026, for approximately $699K combined under prearranged Rule 10b5-1 trading plans.
• Non-Market Transactions: Fredric J. Tomczyk reported 14,818 shares associated with an October 12, 2026 equity-award exercise and corresponding share withholding. These transactions should not be interpreted as discretionary open-market sales.
• Sentiment Interpretation: The absence of recent open-market buying does not establish negative inside information. The disclosed sales are relatively small compared with Cboe’s market capitalization, while predetermined transactions offer limited evidence about management’s near-term expectations.

Q5-A3. Is Cboe Global Markets’ Management Aligned With Shareholders?

• Governance Structure: Cboe operates with conventional publicly traded common equity rather than a founder-controlled dual-class arrangement, supporting relatively straightforward shareholder voting rights.
• Executive Incentives: Performance-linked compensation and equity awards provide exposure to shareholder outcomes. The quality of alignment depends on whether awards reward sustainable EPS, earnings quality, and long-term returns rather than purely transaction-volume expansion.
• Ownership Alignment: Insider ownership is approximately 0.25%, meaning executives have financial exposure but do not possess a controlling shareholder stake.
• Capital Allocation Alignment: Share repurchases and dividends can enhance per-share value, although compensation-related dilution and repurchases at high prices remain important considerations.

Q5-A4. Step 5 Key Takeaways

• Scoring Rationale:
  • Management Trust (5/5): Repeated guidance increases, reduced expense targets, and successful long-term licensing negotiations demonstrate strong recent execution.
  • Insider Trends (2/5): Open-market transactions show net selling without corresponding discretionary purchases, although several sales were relatively small or prearranged.
  • Governance·Compensation System (4/5): Conventional shareholder governance and performance-linked incentives provide reasonable alignment, offset by low insider ownership.
• 📊 Step 5 Score: 11/15 pts (Management Trust 5/5 + Insider Trends 2/5 + Governance·Compensation System 4/5)
• Step 5 Summary: Management’s operating and strategic execution has been convincing, while insider trading offers limited positive confirmation. Shareholder alignment is adequate but not exceptional.

⛵ Step 6: Cboe Global Markets Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Cboe Global Markets Guidance

• Company Guidance: Cboe raised FY2026 organic net-revenue growth expectations to the high teens and reduced annual adjusted operating expense guidance to $830M-$845M.
• Consensus Context: Compiled analyst sentiment is approximately Hold, with an average twelve-month price target near $350.07. The narrow implied appreciation relative to the prevailing quotation indicates that much of the operating strength is already anticipated.
• Guidance Gap: A directly comparable current net-revenue and adjusted-EPS consensus midpoint could not be established after the Q3 release, preventing a reliable numerical company-guidance-minus-consensus calculation.
• Sentiment Direction: The Q3 results provided positive revision evidence through stronger reported profitability and upgraded company guidance. A complete 90-day analyst estimate-revision series was not available.

Q6-A2. What Is Cboe Global Markets’ Short Interest?

• Institutional Ownership: Approximately 89.8% of outstanding shares are institutionally owned, consistent with Cboe’s established position among large-cap financial-infrastructure companies.
• Short Interest: As of October 15, 2026, approximately 2.97M shares were sold short, representing about 2.82% of float.
• Days to Cover: Approximately 2.3 trading days based on the applicable reporting-period average volume, indicating limited short-squeeze pressure.
• Short Interest Direction: Reported short positions declined approximately 10.8% from the preceding settlement report, suggesting that bearish positioning was easing before the strong Q3 earnings announcement.
• Market Interpretation: Short interest is not elevated enough to constitute a major standalone catalyst. Earnings and derivatives-volume developments are more important than short-covering mechanics.

Q6-A3. Step 6 Key Takeaways

• Scoring Rationale:
  • Consensus vs Guidance (2/3): Higher company guidance supports positive expectations, but directly comparable post-results consensus estimates remain incomplete.
  • Supply·Short Interest (2/2): Manageable short interest, declining bearish positioning, and substantial institutional ownership indicate limited technical stress.
• 📊 Step 6 Score: 4/5 pts (Consensus vs Guidance 2/3 + Supply·Short Interest 2/2)
• Step 6 Summary: Market positioning is constructive without being driven by a short squeeze. The principal issue is whether future earnings outperformance can exceed an already favorable market assessment.

🚀 Step 7: Cboe Global Markets Catalysts & Price Triggers

Q7-A1. What Could Move Cboe Global Markets Stock? (Top 3 Catalysts)

• 1 Continued SPX and Short-Dated Options Growth
  • Timing: Q4 2026 through the first three quarters of 2027.
  • Success Conditions: Index-options volume remains elevated, while Cboe preserves pricing economics and converts transaction growth into higher adjusted operating earnings.
  • Failure Risk: Lower realized volatility or reduced hedging activity causes transaction volumes to normalize faster than anticipated.
• 2 Data Vantage Revenue Acceleration
  • Timing: FY2026 annual results and 2027 quarterly disclosures.
  • Success Conditions: Organic Data Vantage net-revenue growth sustains the mid-teens trajectory, increasing recurring revenue and reducing dependence on transaction volumes.
  • Failure Risk: Connectivity pricing pressure, market-data competition, or slower customer adoption limits growth.
• 3 New Event Contracts and Broader Product Innovation
  • Timing: November 2026 launch period through 2027.
  • Success Conditions: Regulatory approvals translate into commercially meaningful product adoption, sustained volumes, and incremental transaction revenue.
  • Failure Risk: Insufficient liquidity, limited customer demand, or additional regulatory restrictions prevent meaningful commercialization.

Q7-A2. Cboe Global Markets’ Earnings Revision Trend

• Reported Earnings Momentum: Q3 adjusted diluted EPS increased 36% to $3.63, following Q2 adjusted EPS growth of 45% to $3.56. These results provide a strong operational basis for upward revisions.
• Management Expectations: Successive increases in organic net-revenue growth guidance and lower expected adjusted expenses indicate a positive company-led earnings trajectory.
• Consensus Revision Evidence: A complete comparable 90-day EPS estimate history was not established. Therefore, reported earnings acceleration and management guidance provide stronger evidence than an assumed quantitative consensus-revision rate.
• Trend Assessment: Improving ⬆️ — operational earnings momentum remains favorable, although the eventual growth rate may moderate against strong 2026 comparisons.

Q7-A3. Step 7 Key Takeaways

• Scoring Rationale:
  • Catalyst (6/7): Proprietary derivatives, Data Vantage growth, and new product opportunities provide credible catalysts, with substantial dependence on trading activity.
  • EPS Trend (2/3): Strong reported adjusted EPS growth and upgraded management guidance support positive earnings expectations, despite incomplete analyst-revision history.
• 📊 Step 7 Score: 8/10 pts (Catalyst 6/7 + EPS Trend 2/3)
• Step 7 Summary: Earnings momentum and proprietary derivatives provide attractive potential catalysts. New initiatives offer optionality but should not be treated as proven contributors to near-term financial forecasts.

⚖️ Step 8: Is Cboe Global Markets Fairly Valued? Valuation Analysis

Q8-A1. Cboe Global Markets’ Key Valuation Multiples

• PE Ratio: 24.54x (fairly valued) — trailing GAAP earnings include nonrecurring effects.
• PS Ratio: 6.63x (fairly valued) — based on gross reported revenue rather than economically comparable net revenue.
• PB Ratio: 5.91x (overvalued) — substantial premium to accounting equity, supported partly by intangible exchange franchise value.
• P/TBV Ratio: 21.35x (overvalued) — tangible book value is a weak standalone measure for a proprietary intellectual-property and network business.
• P/FCF Ratio: 13.84x (fairly valued) — headline FCF is inflated by material operating-balance movements.
• P/OCF Ratio: 13.33x (fairly valued) — cash-flow normalization is essential.
• EV/Sales Ratio: 6.43x (fairly valued) — revenue presentation reduces direct peer comparability.
• EV/EBITDA Ratio: 16.71x (fairly valued) — supported by strong margins and operating returns.
• EV/EBIT Ratio: 17.64x (fairly valued) — attractive operating quality offsets a substantial earnings multiple.
• EV/FCF Ratio: 13.41x (fairly valued) — the denominator contains nonrecurring working-capital effects.
• Forward PE: 22.82x (fairly valued) — requires continued earnings growth to support the current valuation.
• PEG Ratio: 1.24x (fairly valued) — sensitive to the growth estimate and its forecast horizon.
• Scoring Rationale: Cboe trades at a meaningful premium to ordinary financial businesses, but its licensing moat, capital efficiency, and operating margins support a higher multiple. The forward earnings valuation is reasonable rather than demonstrably cheap, particularly after the strong 2026 rally.
• 📌 (1) Axis Q8-A1 Score: -1

Q8-A2. Cboe Global Markets vs Peers: Valuation Comparison

• Multiple selection based on peer comparison: Forward P/E is the preferred measure for comparing recurring shareholder earnings across Cboe, CME Group, Intercontinental Exchange, and Nasdaq. Differences in business mix, accounting adjustments, and forecast periods must be controlled.
• Calculation of peer-to-peer deviation rate: A reliable contemporaneous arithmetic peer mean using identical forecast horizons and earnings definitions could not be established.
  • 🧮 Calculation Formula: ((Cboe forward P/E 22.82x - comparable peer mean unavailable) / comparable peer mean unavailable) × 100 = N/A.
• Scoring Rationale: CME offers greater futures exposure, ICE has substantial data and clearing operations, and Nasdaq has a different financial-technology revenue mix. Without a verified common-date, common-definition peer mean, a numerical premium or discount would create unsupported precision.
• 📌 (2) Axis Q8-A2 Score: 0

Q8-A3. Is Cboe Global Markets Cheap or Expensive vs Its History?

• Comparison Indicators: Trailing GAAP P/E, using five consecutive fiscal-year-end observations from FY2021 through FY2025. The observed multiples are 26.37x, 56.86x, 24.88x, 26.88x, and 23.99x, respectively. Minimum = 23.99x, maximum = 56.86x, and current November 2026 P/E = 24.54x. Observed annual-endpoint position = (24.54 - 23.99) / (56.86 - 23.99) × 100 = 1.7%.
• Scoring Rationale: The current trailing multiple is near the bottom of the five-year annual-endpoint sample. FY2022’s unusually high multiple reflects depressed accounting earnings and widens the historical range, limiting the apparent cheapness signal. The comparison indicates a low observed-range position rather than an independently established intrinsic-value discount.
• 📌 (3) Axis Q8-A3 Score: +4

Q8-A4. What Growth Is Priced Into Cboe Global Markets? (Reverse DCF)

• Implied Growth Rate: Not independently established.
  • 1 Methodology: A shareholder-cash-flow reverse DCF would discount forecast distributable equity cash flow at the cost of equity against the current market capitalization.
  • 2 Core assumptions: The standardized TTM FCF base includes approximately $1.46B of other net operating-asset cash inflows, making it unsuitable as a stable recurring starting base without a more detailed clearing and settlement reconciliation.
• Achievable Growth Rate: Not directly comparable on a defensible normalized FCFE basis.
  • Basis: The company’s high-teens FY2026 organic net-revenue target is not equivalent to long-term distributable equity cash-flow growth.
• Growth gap and difficulty assessment:
  • 🧮 Formula: Achievable normalized FCFE growth - implied normalized FCFE growth = N/A.
• Scoring Rationale: Cboe’s clearing-related operating-balance movements materially distort its reported cash-flow base, while a consistent normalized shareholder-cash-flow forecast cannot be established from the available reporting detail. A forward earnings growth-hurdle comparison provides a more defensible assessment.
• 📌 (4) Axis Q8-A4 Score: ➖

Q8-A4-1. What Growth Hurdle Does the Market Demand From Cboe Global Markets? (Reverse DCF Alternative)

• Scoring Rationale: A forward P/E of 22.82x requires substantial confidence in continued adjusted earnings growth. Cboe’s recent 36% quarterly adjusted EPS expansion supports the valuation, but such unusually strong growth is unlikely to persist indefinitely without continued derivatives-volume expansion. The current multiple requires somewhat stronger-than-normal earnings delivery rather than merely stable profitability.
• 📌 (4) Axis Q8-A4-1 Score: -2

Q8-A5. Cboe Global Markets’ Hidden Asset & Stake Valuation

• Scoring Rationale: Not applicable — Cboe’s economic value is primarily embedded in its operating exchange franchises and contractual licenses, while sufficiently large independently separable investment holdings meeting the specified valuation threshold could not be established.
• 📌 (5) Axis Q8-A5 Score: ➖

Q8-A6. Final Valuation Adjustment

• Scoring Rationale: The long-term S&P licensing extension strengthens franchise visibility, but that advantage is already incorporated into the economic-moat assessment and the justified operating valuation. No additional distinct material factor warrants a separate adjustment.
• 📌 (6) Axis Q8-A6 Score: 0

Q8-A7. Valuation Adjustment Score Calculation

• Calculation Process:
  • (1) Axis (Key Valuation Indicators): -1 pts (Fairly Valued)
  • (2) Axis (Peer-to-peer deviation rate): 0 pts (Comparable peer deviation unavailable)
  • (3) Axis (Historical Band Position): +4 pts (observed-range position p = 1.7%; very undervalued historical-band tier)
  • (4) Axis (Justification for Growth): -2 pts (Forward earnings valuation requires sustained above-normal growth)
  • (5) Axis (Held assets·Share Valuation): 0 pts (Not applicable)
  • (6) Axis (Final adjustment): 0 pts (No additional distinct adjustment)
• 📊 Valuation Adjustment Score: A1 (-1) + A2 (0) + A3 (+4) + A4 (-2) + A5 (0) + A6 (0) = +1 pts
• Commentary: Cboe’s trailing multiple sits near the lower end of its annual historical sample, although distorted historical earnings limit that signal. Strong profitability supports its current valuation, but continued growth is needed to justify further appreciation.
• Step 8 Summary: Cboe appears reasonably valued on forward operating fundamentals. Its apparent historical cheapness should not be interpreted as a large independent margin of safety.

💀 Step 9: What Are the Risks of Cboe Global Markets? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Cboe Global Markets?

• 1 Dependence on proprietary index-derivatives trading activity:
  • Cause: A substantial portion of earnings depends on trading volume and demand for SPX, VIX, and related derivatives.
  • Impact: A sustained reduction in transaction activity could slow net-revenue growth and reverse some of the recent operating leverage.
  • Mitigation/Monitoring Indicators: Track index-options average daily volume, revenue per contract, derivatives net revenue, and adjusted operating margins.
• 2 Regulatory changes affecting exchange economics and product availability:
  • Cause: Exchanges face extensive market-structure, trading, clearing, and investor-protection regulation.
  • Impact: Restrictions on product design, transaction fees, or trading access could reduce revenue opportunities or increase compliance expenses.
  • Mitigation/Monitoring Indicators: Monitor SEC and CFTC rulemaking, product approvals, exchange-fee developments, and relevant enforcement actions.
• 3 Technology and market-operational disruption:
  • Cause: Electronic exchanges depend on uninterrupted matching engines, connectivity, cybersecurity, data integrity, and clearing operations.
  • Impact: A serious outage or security incident could damage confidence, cause financial liabilities, and weaken institutional customer relationships.
  • Mitigation/Monitoring Indicators: Track system availability, operational incidents, regulatory findings, and technology-resilience expenditures.

Q9-A2. How Sensitive Is Cboe Global Markets to the Economy?

• 1 Higher Market Volatility (Positive Impact ⬆): Increased hedging and options activity can raise derivatives transaction revenue, provided market functioning remains orderly.
• 2 Restrictive Trading Regulation (Negative Impact ⬇): Restrictions affecting popular derivatives products or exchange-fee structures could reduce transaction volumes and operating profitability.
• 3 Higher Interest Rates (Negative Impact ⬇): Higher discount rates and changes in institutional asset allocation can pressure financial-market activity and increase the cost of financing growth initiatives.

Q9-A3. Cboe Global Markets Pre-Mortem: What Could Go Wrong?

• 1 A prolonged collapse in index-options activity: Market volatility normalizes, short-dated options trading loses momentum, and institutional hedging activity declines, causing a substantial reduction in earnings expectations.
  • Early Warning Signal: Multiple consecutive quarters of declining SPX options activity and derivatives net revenue.
• 2 Regulatory intervention disrupts proprietary derivatives economics: Authorities impose restrictions or product-design changes that make key contracts less attractive to users or limit monetization.
  • Early Warning Signal: Formal regulatory proposals or orders directly targeting economically important exchange products.
• 3 A major exchange-system failure damages institutional confidence: A prolonged outage or cybersecurity event causes material trading disruption, litigation exposure, and customer migration.
  • Early Warning Signal: Repeated critical trading outages, unresolved operational findings, or escalating system-integrity incidents.

Q9-A4. Risk Adjustment Score

• Reason for Scoring: Cboe’s principal risks involve trading-volume cyclicality, financial-market regulation, and operational concentration. Recent results show strong earnings growth rather than a verified continuing financial impairment. Low leverage, diversified market infrastructure, and long-term product licensing provide substantial mitigants, although severe regulatory or technology incidents remain possible.
• 📊 Risk Adjustment Score: -3 pts
• Step 9 Summary: The business faces meaningful operating and regulatory risks, but current evidence supports manageable downside exposure rather than a demonstrated structural deterioration.

🎯 Step 10: Cboe Global Markets Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

• Investment Score Calculation Formula:
  • Step breakdown: S2 (22) + S3 (23) + S4 (17) + S5 (11) + S6 (4) + S7 (8) = 85 pts
  • Steps 2-7 Sum (85 pts) + Valuation Adjustment (+1 pts) + Risk Adjustment (-3 pts) = Investment Score 83 pts
• Investment Score & Rating: 83 pts (A Rating ⭐⭐⭐⭐)
  • Commentary: An exceptional exchange moat, accelerating operating earnings, high returns on capital, and strong financial resilience underpin the investment case. Valuation is less compelling than the business quality, while modest insider confirmation and trading-volume dependence temper the outlook.

Q10-A2. Should You Buy Cboe Global Markets? (Recommendation)

• Recommendation: Buy
  • Commentary: Cboe offers a differentiated combination of proprietary financial infrastructure, high operating margins, and structural derivatives demand. However, the sharp 2026 appreciation has reduced the near-term margin of safety, making disciplined entry valuation more attractive than indiscriminate buying at current prices.

Q10-A3. Investment Thesis in One Line

• Cboe’s proprietary index-derivatives network, strong margins, and durable licensing moat support long-term earnings compounding, but elevated expectations and dependence on trading activity constrain near-term upside.

Q10-A4. Cboe Global Markets’ Price Trend & Key Drivers

• Stock Price Trend Over the Past 12 Months: Strong Upward Trend 📈 — Cboe’s shares increased approximately 40% over the latest 52-week observation period, with an observed range of $227.15-$371.18. The increase reflects stronger exchange profitability and favorable demand for derivatives.
• July 31, 2026 Q2 Earnings and Upgraded Growth Expectations
  • Description: Net revenue grew 25%, adjusted EPS advanced 45%, and management increased the annual organic growth outlook.
  • Stock Price Reaction: Constructive Trading 📈 — Shares traded near $310.23 on the release date after a period of substantial volatility; the subsequent performance reflected ongoing reassessment of strong earnings and derivatives activity rather than a reliably isolated announcement-day effect.
• October 30, 2026 Q3 Earnings Beat and Stronger FY2026 Guidance
  • Description: Adjusted EPS increased 36% and net revenue rose 18%, while management raised organic growth expectations and reduced expense guidance.
  • Stock Price Reaction: Sharp Rise 📈 — The stock advanced from $314.25 on October 29 to $335.53 at the October 30 close, a gain of approximately 6.8% during the earnings-release session.

Q10-A5. Action Plan

• Current Price: $346.36
• Buy Zone: $320.00 ($310.00–$330.00)
  • (1) Calculation of Fundamental Value: A preferred entry range of $310.00-$330.00 provides a modest valuation discount to the base-case target while recognizing Cboe’s resilient operating economics and strong returns on capital.
  • (2) Momentum Premium/Discount Application: The established upward trend and strong derivatives earnings support some valuation premium, but the recent earnings-driven rally does not justify abandoning price discipline.
  • (3) Conclusion: The appropriate purchase range is $310.00-$330.00, with a $320.00 midpoint. This offers a more attractive entry relative to normalized earnings and the risks of volume normalization.
• Price Target: $363.40
• Expected Return: +4.9% (vs. current price)
  • 📍 Selected Valuation Metric: FY2027 normalized adjusted EPS multiplied by a justified forward P/E — a suitable method for a profitable exchange operator with relatively low conventional leverage.
  • 🧮 Price Target Calculation Formula: FY2027 estimated adjusted EPS $15.80 × target P/E 23.0x = $363.40
  • ⚓ Valuation Basis and Key Assumptions: The $15.80 FY2027 EPS estimate is an independent analytical scenario, not company guidance or confirmed consensus. It assumes FY2026 adjusted EPS of approximately $14.50, followed by around 9% growth as derivatives activity remains constructive and Data Vantage expands. A 23.0x forward multiple reflects Cboe’s durable product licenses, high returns, and attractive operating margins, within a broad justified range of approximately 21x-25x for its normalized earnings profile. The modest target appreciation reflects a business already trading at a substantial premium to ordinary financial companies; the historically low trailing P/E position in Step 8 is less decisive because past accounting distortions widen that comparison range. The target is sensitive to derivatives volumes and realized fee economics.
• Conditions and timing for reaching price target: The six-to-twelve-month base case depends on the FY2026 results release and subsequent 2027 quarterly disclosures confirming that derivatives growth, mid-teens Data Vantage expansion, and expense discipline support sustainable adjusted EPS growth.
• Stop Loss: $280.00 ($275.00–$285.00)
• Action trigger upon catalyst achievement:
  • 1 Derivatives Net Revenue Sustains Double-Digit Growth
    • Description: Confirm whether trading activity and realized pricing support continued adjusted EPS expansion before increasing exposure. 👉 Maintain Holdings (Hold)
  • 2 Data Vantage Delivers Sustained Mid-Teens Organic Growth
    • Description: More durable data revenue strengthens earnings quality and may justify reassessing the earnings multiple if the improvement is not already reflected in the share price. 👉 Consider Additional Buying (Buy)
  • 3 Event Contracts Establish Meaningful Commercial Adoption
    • Description: Assess incremental transaction economics and actual profitability before assigning additional value to the new product category. 👉 Maintain Holdings (Hold)
• Action trigger upon risk realization:
  • 1 Sustained Decline in SPX Options Volume
    • Description: Multiple quarters of weakening activity would undermine the core earnings-growth assumptions and warrant a lower valuation estimate. 👉 Reduce Holdings (Sell)
  • 2 Material Restrictions on Proprietary Derivatives Products
    • Description: A binding regulatory action that damages the economic viability of major products would weaken the investment thesis. 👉 Reduce Holdings (Sell)
  • 3 Major Operational or Cybersecurity Incident
    • Description: A serious disruption causing financial losses or sustained institutional customer defections requires an immediate reassessment of franchise durability. 👉 Reduce Holdings (Sell)
• Customized Strategy Guide by Investment Preference:
  • Defensive Investors: Favor incremental purchases within the $310.00-$330.00 range, subject to stable earnings estimates and no deterioration in regulatory or operational conditions. Avoid chasing large post-earnings advances.
  • Neutral Investors: Establish positions gradually, prioritizing attractive entry prices and reviewing exposure following the FY2026 results release.
  • Aggressive Investors: A small initial allocation may be justified by strong operating momentum, with larger additions dependent on a favorable entry valuation or further evidence of sustainable derivatives and data growth.

🕵️‍♂️ Deep Dive Analysis

Q1: Is Cboe Global Markets’ Dependence on SPX and VIX Derivatives Its Biggest Structural Weakness?

• Analysis: Proprietary index derivatives account for the majority of Cboe’s net revenue, and a significant portion of recent growth comes from rising index-options activity. Concentration creates exceptional economics when volumes expand but also magnifies the impact of sustained changes in hedging demand, short-dated options usage, or market structure. The licensing extension through 2051 protects access to important products but does not guarantee trading volumes or eliminate regulatory exposure.
• Judgment: Moderately Negative — Concentration is economically valuable because it creates pricing power, but it remains the company’s principal earnings sensitivity.

Q2: Can Cboe Global Markets’ Approximately 23x Forward P/E Be Justified by Its Proprietary Exchange Franchise?

• Analysis: A forward earnings multiple in the low twenties is consistent with a high-quality exchange operator possessing durable licenses, strong operating margins, and substantial returns on invested capital. The valuation becomes less attractive if earnings growth reverts quickly toward low-single-digit levels. Conversely, sustained double-digit derivatives and data growth could justify the current premium.
• Judgment: Fairly Valued — Quality supports the premium, but near-term upside is limited without additional earnings expansion.

Q3: Will Zero-Day-to-Expiration Options Continue Driving Cboe Global Markets’ Growth?

• Analysis: Short-dated index options have expanded trading frequency and increased demand for precise intraday risk management. Growth may continue through broader institutional and international adoption, but the existing activity base is already substantial. The most important question is whether incremental trading reflects durable investment and hedging behavior rather than a temporary speculative wave.
• Judgment: Positive with Cyclical Exposure — Continued adoption is plausible, although extrapolating recent exceptionally strong volume growth indefinitely would be aggressive.

Q4: Does Cboe Global Markets’ S&P License Extension Through 2051 Create an Almost Unassailable Moat?

• Analysis: The extension eliminates a major long-term licensing uncertainty and limits direct substitution of Cboe’s proprietary S&P-linked products. However, investors can use economically related products, including futures and ETFs, to pursue similar risk exposures. The agreement protects essential intellectual-property access but cannot prevent all competitive substitution.
• Judgment: Strongly Positive — Contract duration substantially reinforces franchise durability without establishing an absolute monopoly.

Q5: Can Cboe Global Markets’ Data Vantage Business Reduce Dependence on Trading Volumes?

• Analysis: Data Vantage represented approximately 25% of Q3 2026 net revenue and grew around 13% YoY. Its access, connectivity, and information services provide recurring relationships and support diversification. However, market-data consumption and connectivity demand still depend partly on trading infrastructure activity, preventing complete separation from market cycles.
• Judgment: Positive — Data Vantage improves revenue durability, but derivatives will remain the dominant earnings driver for the foreseeable future.

Q6: Are Cboe Global Markets’ Exceptional Operating Margins Sustainable?

• Analysis: Q3 adjusted operating margin reached 71.4%, reflecting strong proprietary product economics and disciplined costs. Such margins are supported by limited physical capital requirements and substantial fixed-cost leverage. However, weaker transaction volumes, a less favorable product mix, or increased technology and regulatory spending could reduce incremental profitability.
• Judgment: Positive — High margins are structurally supported, but continued expansion at the recent pace should not be assumed.

Q7: How Much of Cboe Global Markets’ 2026 Earnings Growth Is Truly Recurring?

• Analysis: Adjusted EPS growth provides stronger evidence of recurring performance than GAAP earnings alone because the latter includes a material divestiture gain. However, adjusted profit still benefits from unusually favorable derivatives trading activity. Revenue linked to repeatable trading behavior is operationally recurring in a broad sense, but volume-sensitive earnings do not have the contractual predictability of subscription revenue.
• Judgment: Positive with Normalization Risk — Earnings quality is strong, although sustainable growth should be estimated below the latest quarterly expansion rate.

Q8: Could Regulatory Changes Undermine Cboe Global Markets’ Event-Contract and Options Expansion?

• Analysis: Exchanges must operate within evolving regulatory rules governing product approval, trading access, investor protection, and market integrity. Cboe’s event-contract opportunity creates potential incremental revenue, but the commercial market remains young and regulatory acceptance is not equivalent to sustained adoption. More importantly, rule changes affecting established options markets would have a much larger earnings impact than the failure of a newly launched initiative.
• Judgment: Moderately Negative — Regulation is a persistent operating constraint, with the greatest economic exposure concentrated in established derivatives products.

Q9: Does Cboe Global Markets’ Cash Flow Overstate Its Sustainable Owner Earnings?

• Analysis: Standardized TTM FCF exceeds $2.5B, but a substantial portion of reported operating cash flow arises from movements in other net operating assets. Exchange and clearing organizations can experience large cash-flow fluctuations associated with settlement and collateral mechanics. Applying the headline FCF directly to a perpetual DCF would risk treating temporary or restricted cash movements as permanently distributable shareholder cash.
• Judgment: Neutral — Strong underlying earnings and modest capital expenditure support cash generation, but normalized operating income and adjusted EPS are currently more reliable valuation anchors.

Q10: Is Cboe Global Markets Better Positioned for Long-Term Compounding Than Near-Term Price Appreciation?

• Analysis: Cboe possesses the principal characteristics of a durable compounder: contractual intellectual-property advantages, network effects, scalable operations, and high returns on capital. Yet strong 2026 share-price appreciation has already incorporated much of the recent earnings acceleration. The longer-term case can remain attractive even when near-term expected appreciation is modest, provided earnings continue compounding and the franchise retains its competitive advantages.
• Judgment: Positive Long-Term, Selective Near-Term — Cboe is an attractive quality franchise, but entry valuation matters more after the recent rerating.